In addition, the CCL2/CCR2 axis can promote cell survival by inhibiting autophagic death and apoptosis of cancer cells by activating the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR)-dependent pathway (45, 46). Here, CCL2 is linked to cancer.